Sign in

CIK 0001745999 · Large accelerated filer

Beam Therapeutics Inc.

Sign in to watch
Ticker
BEAM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
857-327-8775
Business address
26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
Former names
Beam Therapeutics Inc.
  1. 4 Grant or award Chief Financial Officer acquired 27,500 shares (grant or award)
  2. 4 Grant or award Chief Medical Officer acquired 27,500 shares (grant or award)
  3. 4 Grant or award President acquired 35,000 shares (grant or award)
  4. 4 Grant or award Chief Legal Officer acquired 27,500 shares (grant or award)
  5. 4 Planned sale CEO sold 60,000 shares at $33.86 ($2,031,402)
  6. 4 Open-market sale See Remark 1 sold 901,565 shares at an average $30.55 ($27,545,051)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Planned sale CEO sold 60,000 shares at $25.33 ($1,519,800)
  11. 4 Derivatives Options or other derivatives
  12. 4 Planned sale Chief Legal Officer sold 1,907 shares at $26.42 ($50,383)
  13. 4 Other disposition 10% owner disposed of 29,549 shares (other)
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 4 Planned sale Chief Legal Officer sold 10,000 shares at an average $30.50 ($305,000)
  17. 4 Planned sale Chief Medical Officer sold 3,448 shares at $18.70 ($64,478)
  18. 4 Option exercise President and CSO acquired 90,900 shares (option exercise)
  19. 4 Planned sale Chief Legal Officer sold 388 shares at $22.85 ($8,866)
  20. 4 Planned sale Chief Medical Officer sold 391 shares at $30.48 ($11,918)

Page 6 of 12 · 238 filings